Advertisement

Topics

PHARMA DISCOVERY An Elsevier Event Company Profile

10:49 EST 15th December 2018 | BioPortfolio

Nil

Location

United States of America

Contact

Phone: 203-840-5642
Fax: 203-840-9642
Email: inquiry@pharmadiscoveryevent.com


News Articles [1403 Associated News Articles listed on BioPortfolio]

Elsevier Selected for NHS England Health Systems Support Framework

LONDON, October 16, 2018 /PRNewswire/ -- Elsevier among top suppliers revolutionising the NHS through digital transformation Elsevier, the global information analytics business specializing in science...

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation

Elsevier launches Entellect Platform, unlocking value by creating AI-ready life sciences data

Entellect leverages Elsevier s unique heritage to help enrich data and help companies overcome challenges in modern R&D

Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data

Entellect leverages Elsevier’s unique heritage to help enrich data and help companies overcome challenges in modern R&D

Elsevier platform makes data ‘AI-ready’ to help researchers overcome R&D challenges

The information analytics business Elsevier has launched a new cloud-based data platform, Entellect, to de-silo, contextualize, and connect drug, target, and disease data.

Expert Explains the Potential of AI in Drug Discovery, Healthcare

ArticleMatthew Clark, PhD, Director of Scientific Services at Elsevier, said that by tapping into AI researchers could someday enhance treatments for disease.

Elsevier introduces cloud-based platform for life sciences companies

Science and health analytics firm Elsevier has introduced a new cloud-based platform to support life sciences companies in addressing the...Read More... The post Elsevier introduces cloud-based platfo...

South Asia's largest pharma event CPhI and P─MEC India gets underway in Delhi

The 12th edition of CPhI and P─MEC India, South Asia's largest pharma event, got underway in Delhi. More than 1,600 exhibitors from over 42 countries are taking part in the three─day event.

Drugs and Medications [286 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [915 Associated PubMed Articles listed on BioPortfolio]

Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm.

The need for new antimicrobials is indisputable. The flight from natural products in drug discovery was unfortunate. However, the revolution that is genome mining, enabled by the explosion in sequenci...

Leveraging Semantic Labels for Multi-level Abstraction in Medical Process Mining and Trace Comparison.

Many medical information systems record data about the executed process instances in the form of an event log. In this paper, we present a framework, able to convert actions in the event log into high...

Knut Wester (ed.): Arachnoid cysts : Vol 1-2, Academic Press/Elsevier, 2018 (ISBN: 978-0-12-809932-2).

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System.

The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) is an important source for detecting adverse drug event (ADE) signals. In this article, we propose a three-component mi...

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical Trials [1195 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

Companies [2123 Associated Companies listed on BioPortfolio]

PHARMA DISCOVERY An Elsevier Event

Nil

Elsevier MDL

Elsevier MDL is the pioneering leader in discovery informatics. Over 1,000 life science companies supercharge their discovery engines with MDL software solutions to generate fresh ideas and make break...

Elsevier Properties and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Tr...

Elsevier Properties SA and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks i...

Elsevier and Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases...

More Information about "PHARMA DISCOVERY An Elsevier Event" on BioPortfolio

We have published hundreds of PHARMA DISCOVERY An Elsevier Event news stories on BioPortfolio along with dozens of PHARMA DISCOVERY An Elsevier Event Clinical Trials and PubMed Articles about PHARMA DISCOVERY An Elsevier Event for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PHARMA DISCOVERY An Elsevier Event Companies in our database. You can also find out about relevant PHARMA DISCOVERY An Elsevier Event Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record